GDPR statement

Information Security and Data Protection are pivotal to CIS Oncology’s business, and as such the introduction of GDPR, which came into force in May 2018, is a welcome opportunity to review and refresh such activity within our organisation.

CIS is committed to the highest standards of data protection and information security, and we operate an Information Security Management System (ISMS) which adheres to the highest recognised standards, including ISO27001.

Our GDPR preparation has included a comprehensive review of all internal processes, procedures and associated documentation to ensure full readiness.

CIS Oncology is compliant with all applicable GDPR regulations, and will work closely and collaboratively with all customers, partners and peers to facilitate compliance with its requirements as widely as possible.

We are also committed to ongoing review and vigilance on all matters within the scope of GDPR, so that a process of continual reappraisal, training, risk management and improvement is embedded in our organisation.

Any questions relating to GDPR and CIS can be referred in the first instance to